EGFR signaling promotes TGFβ-dependent renal fibrosis

Jianchun Chen, Jiankang Chen, Kojiro Nagai, David Plieth, Mingqi Tan, Tang Cheng Lee, David W. Threadgill, Eric G. Neilson, Raymond C. Harris

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

The mechanisms by which angiotensin II (Ang II) promotes renal fibrosis remain incompletely understood. Ang II both stimulates TGFβ signaling and activates the EGF receptor (EGFR), but the relative contribution of these pathways to renal fibrogenesis is unknown. Using a murine model with EGFR-deficient proximal tubules, we demonstrate that upstream activation of EGFR-dependent ERK signaling is critical for mediating sustained TGFβ expression in renal fibrosis. Persistent activation of the Ang II receptor stimulated ROS-dependent phosphorylation of Src, leading to sustained EGFR-dependent signaling for TGFβ expression. Either genetic or pharmacologic inhibition of EGFR significantly decreased TGFβ-mediated fibrogenesis. We conclude that TGFβ-mediated tissue fibrosis relies on a persistent feed-forward mechanism of EGFR/ERK activation through an unexpected signaling pathway, highlighting EGFR as a potential therapeutic target for modulating tissue fibrogenesis.

Original languageEnglish (US)
Pages (from-to)215-224
Number of pages10
JournalJournal of the American Society of Nephrology
Volume23
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

Epidermal Growth Factor Receptor
Fibrosis
Kidney
Angiotensin II
Angiotensin Receptors
Phosphorylation

ASJC Scopus subject areas

  • Nephrology

Cite this

Chen, J., Chen, J., Nagai, K., Plieth, D., Tan, M., Lee, T. C., ... Harris, R. C. (2012). EGFR signaling promotes TGFβ-dependent renal fibrosis. Journal of the American Society of Nephrology, 23(2), 215-224. https://doi.org/10.1681/ASN.2011070645

EGFR signaling promotes TGFβ-dependent renal fibrosis. / Chen, Jianchun; Chen, Jiankang; Nagai, Kojiro; Plieth, David; Tan, Mingqi; Lee, Tang Cheng; Threadgill, David W.; Neilson, Eric G.; Harris, Raymond C.

In: Journal of the American Society of Nephrology, Vol. 23, No. 2, 01.02.2012, p. 215-224.

Research output: Contribution to journalArticle

Chen, J, Chen, J, Nagai, K, Plieth, D, Tan, M, Lee, TC, Threadgill, DW, Neilson, EG & Harris, RC 2012, 'EGFR signaling promotes TGFβ-dependent renal fibrosis', Journal of the American Society of Nephrology, vol. 23, no. 2, pp. 215-224. https://doi.org/10.1681/ASN.2011070645
Chen, Jianchun ; Chen, Jiankang ; Nagai, Kojiro ; Plieth, David ; Tan, Mingqi ; Lee, Tang Cheng ; Threadgill, David W. ; Neilson, Eric G. ; Harris, Raymond C. / EGFR signaling promotes TGFβ-dependent renal fibrosis. In: Journal of the American Society of Nephrology. 2012 ; Vol. 23, No. 2. pp. 215-224.
@article{4954efa17cc042d68ca35a422904a799,
title = "EGFR signaling promotes TGFβ-dependent renal fibrosis",
abstract = "The mechanisms by which angiotensin II (Ang II) promotes renal fibrosis remain incompletely understood. Ang II both stimulates TGFβ signaling and activates the EGF receptor (EGFR), but the relative contribution of these pathways to renal fibrogenesis is unknown. Using a murine model with EGFR-deficient proximal tubules, we demonstrate that upstream activation of EGFR-dependent ERK signaling is critical for mediating sustained TGFβ expression in renal fibrosis. Persistent activation of the Ang II receptor stimulated ROS-dependent phosphorylation of Src, leading to sustained EGFR-dependent signaling for TGFβ expression. Either genetic or pharmacologic inhibition of EGFR significantly decreased TGFβ-mediated fibrogenesis. We conclude that TGFβ-mediated tissue fibrosis relies on a persistent feed-forward mechanism of EGFR/ERK activation through an unexpected signaling pathway, highlighting EGFR as a potential therapeutic target for modulating tissue fibrogenesis.",
author = "Jianchun Chen and Jiankang Chen and Kojiro Nagai and David Plieth and Mingqi Tan and Lee, {Tang Cheng} and Threadgill, {David W.} and Neilson, {Eric G.} and Harris, {Raymond C.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1681/ASN.2011070645",
language = "English (US)",
volume = "23",
pages = "215--224",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - EGFR signaling promotes TGFβ-dependent renal fibrosis

AU - Chen, Jianchun

AU - Chen, Jiankang

AU - Nagai, Kojiro

AU - Plieth, David

AU - Tan, Mingqi

AU - Lee, Tang Cheng

AU - Threadgill, David W.

AU - Neilson, Eric G.

AU - Harris, Raymond C.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - The mechanisms by which angiotensin II (Ang II) promotes renal fibrosis remain incompletely understood. Ang II both stimulates TGFβ signaling and activates the EGF receptor (EGFR), but the relative contribution of these pathways to renal fibrogenesis is unknown. Using a murine model with EGFR-deficient proximal tubules, we demonstrate that upstream activation of EGFR-dependent ERK signaling is critical for mediating sustained TGFβ expression in renal fibrosis. Persistent activation of the Ang II receptor stimulated ROS-dependent phosphorylation of Src, leading to sustained EGFR-dependent signaling for TGFβ expression. Either genetic or pharmacologic inhibition of EGFR significantly decreased TGFβ-mediated fibrogenesis. We conclude that TGFβ-mediated tissue fibrosis relies on a persistent feed-forward mechanism of EGFR/ERK activation through an unexpected signaling pathway, highlighting EGFR as a potential therapeutic target for modulating tissue fibrogenesis.

AB - The mechanisms by which angiotensin II (Ang II) promotes renal fibrosis remain incompletely understood. Ang II both stimulates TGFβ signaling and activates the EGF receptor (EGFR), but the relative contribution of these pathways to renal fibrogenesis is unknown. Using a murine model with EGFR-deficient proximal tubules, we demonstrate that upstream activation of EGFR-dependent ERK signaling is critical for mediating sustained TGFβ expression in renal fibrosis. Persistent activation of the Ang II receptor stimulated ROS-dependent phosphorylation of Src, leading to sustained EGFR-dependent signaling for TGFβ expression. Either genetic or pharmacologic inhibition of EGFR significantly decreased TGFβ-mediated fibrogenesis. We conclude that TGFβ-mediated tissue fibrosis relies on a persistent feed-forward mechanism of EGFR/ERK activation through an unexpected signaling pathway, highlighting EGFR as a potential therapeutic target for modulating tissue fibrogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84863116842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863116842&partnerID=8YFLogxK

U2 - 10.1681/ASN.2011070645

DO - 10.1681/ASN.2011070645

M3 - Article

VL - 23

SP - 215

EP - 224

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 2

ER -